OrCam Technologies
Israeli AI assistive technology company developing wearable devices for visually and hearing impaired individuals, founded by Mobileye creators in Jerusalem
Take Action
Apply pressure where it matters. Use these tools and personalise your message with evidence from this page.
- Contact Corporate LeadershipContact OrCam press and communications team
- Report New IntelligenceSubmit evidence of contracts, partnerships, or government ties
- Share This ProfileShare on LinkedIn to reach assistive technology professionals
- Strategic AnalysisIn-depth analysis and engagement strategy
Before taking action, review our Code of Conduct for professional standards and ethical guidelines.
Help Us Hold OrCam Technologies Accountable
Your skills and knowledge can strengthen this campaign. Join our volunteer research team or share insider information securely.
Leverage Your Expertise
Do you work in this sector? We need professionals who understand procurement cycles, regulatory compliance, and corporate governance. Don't just boycott - lead!
Decision-Maker Directory
Key individuals with influence over corporate partnerships and procurement decisions. Direct your correspondence to the most relevant role.
Material Risk Framing
Frame your message around business risks. These talking points resonate with corporate stakeholders and institutional investors.
Medical/assistive device regulations provide some protection; no documented military applications or surveillance technology
Private company with unicorn valuation ($1B+ since 2018); significant venture capital backing; limited public financial disclosure
Assistive technology positioning creates ethical complexity; targeting disabled users complicates boycott messaging
B2B distribution through medical and accessibility channels; partnerships with disability organisations globally
Strategic Analysis
In-depth assessment of the company's position, vulnerabilities, and recommended approaches for effective engagement.
Lower severity, high vulnerability — momentum builders that fold quickly
Learn about our methodology — companies are categorised based on severity (harm potential) vs strategic vulnerability (campaign leverage).
Why do these scores change?
Unlike static boycott lists, our targeting model is dynamic. This company's position on the matrix is re-evaluated continually as we verify new contracts, divestments, or policy changes. Your reporting directly impacts this score.
OrCam Technologies presents a strategically complex boycott target. As an Israeli-headquartered AI company founded by Mobileye creators Amnon Shashua and Ziv Aviram, OrCam contributes to the Israeli technology ecosystem and economy. However, the company's focus on assistive technology for visually and hearing impaired individuals creates significant ethical complexity that distinguishes it from other Israeli technology firms.
Key Leverage Points
- Israeli Economic Contribution: Unicorn-status company headquartered in Israel, contributing tax revenue and reinforcing Israel's technology reputation
- Founder Network: Same founders as Mobileye creates connection to Intel acquisition proceeds and broader Israeli tech ecosystem
- B2B Healthcare Distribution: Distribution through medical and accessibility channels enables institutional procurement pressure
- Private Company Status: Limited public disclosure and no public shareholders reduces investor pressure avenues
Ethical Considerations
OrCam's assistive technology focus creates genuine ethical tension for boycott campaigns. The OrCam MyEye device provides meaningful independence to blind and visually impaired individuals, enabling them to read text, recognise faces, and navigate environments. Unlike surveillance technology or military applications, OrCam's products directly serve vulnerable populations. Campaigns targeting OrCam must carefully consider the impact on disabled users who may have limited alternatives. This does not negate the company's contribution to the Israeli economy, but should inform messaging and prioritisation.
Engagement Strategy
Given the ethical complexity, OrCam should be treated as a monitoring target rather than an active campaign priority. Document the company's Israeli economic contribution and founder connections to Mobileye/Intel. Engage disability advocacy organisations to develop nuanced positions that acknowledge both Palestinian rights and accessibility needs. Focus institutional pressure on healthcare procurement policies while ensuring disabled users are not disproportionately affected. Prioritise higher-impact targets with clearer military, surveillance, or occupation connections before escalating OrCam campaigns.
Evidence & Sources
Verified sources including NGO reports, regulatory filings, and primary documents. Use these to substantiate your correspondence.
OrCam continues recognition as leading accessibility technology innovator
Open sourceConfirms Jerusalem founding in 2010 by Mobileye co-founders Amnon Shashua and Ziv Aviram
Open sourceOrCam CEO receives Israel's highest honour for contributions to technology and enterprise
Open sourceOrCam MyEye named to TIME's list of best inventions for accessibility innovation
Open sourceCompany achieves $1 billion valuation following Series B funding round
Open sourceUpdates & Milestones
- TIME Best Inventions 2024
Continued recognition for accessibility innovation
- Israel Prize Awarded
CEO Amnon Shashua receives Israel Prize for technology contributions
- TIME Recognition Continues
OrCam products again featured in TIME's Best Inventions list
- TIME Best Inventions
OrCam MyEye named to TIME's Best Inventions 2019 list
- Unicorn Valuation
OrCam achieves $1 billion+ valuation following Series B funding round
- OrCam MyEye Launch
First commercial product released - wearable AI device for visually impaired users
- Company Founded
Amnon Shashua and Ziv Aviram found OrCam Technologies in Jerusalem, applying AI to assistive technology